The use of regorafenib for patients with refractory metastatic colorectal cancer in clinical practice

AIM: Patients in clinical practice are relatively vulnerable compared to those enrolled in clinical trials. We focused on analyzing the pattern of regorafenib use in routine clinical practice, which included initial starting dose and follow-up schedule. We also evaluated the efficacy and safety acco...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoon, Sang Eun, Lee, Su Jin, Lee, Jeeyun, Park, Se Hoon, Park, Joon Oh, Lim, Ho Yeong, Kang, Won Ki, Park, Young Suk, Kim, Seung Tae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6309775/
https://www.ncbi.nlm.nih.gov/pubmed/30636885
http://dx.doi.org/10.2147/OTT.S187621

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6309775/
https://www.ncbi.nlm.nih.gov/pubmed/30636885
http://dx.doi.org/10.2147/OTT.S187621

Ejemplares similares